DKT International, which sells millions of abortion pills globally may be shipping abortion drugs into the U.S. manufactured by the Delhi-based Synokem Pharmaceuticals Ltd, which is alleged to have a “shoddy quality record,” according to Bloomberg.com. The outlet also noted that DKT International “has become one of the world’s largest sellers of abortion pills, serving women from India to Mexico.”
According to Bloomberg, “[A]lmost one-fifth of the 30 million products DKT distributes annually for abortions and postpartum hemorrhage prevention come from an Indian company with a record of making substandard medicine.” Bloomberg also alleged:
More than 30 samples of drugs made by Delhi-based Synokem Pharmaceuticals Ltd. — including generic abortion pills… have failed quality tests conducted by Indian regulators and public health researchers since 2018, according to government records and data reviewed by Bloomberg News. The samples contained impurities, lacked the right amount of active ingredient or failed to meet other international standards designed to ensure that medicine is safe and effective, the records show.
In addition, Bloomberg claimed that “[w]hile the inspection reports didn’t flag significant issues, at least 23 samples of Synokem’s drugs have failed quality tests since 2018, according to test results Bloomberg collected from six state and federal drug regulators in India. That’s likely an undercount because most of India’s 36 regional regulators don’t make such results public. One of the tests, involving a misoprostol sample collected at a hospital pharmacy in 2019, had so little active ingredient that a government-run hospital network warned all its members to stop using any medication from the entire batch, official records show,” they wrote.
While Bloomberg claimed that “Synokem abortion pills haven’t been linked to any deaths or serious injuries,” they went on to note that “the company’s product failures, all detected after the drugs had been sold to pharmacies and other distributors, suggest its internal quality assurance system is not working, medical experts consulted about the data told Bloomberg.”
DKT’s founding and funders
DKT International was founded in 1989 by Philip Harvey, who resigned as president in 2013 when he was replaced by Christopher H. Purdy, who serves as the organization’s current CEO. While Harvey passed away in 2021, he regularly funded DKT with money he earned from selling pornographic films and sex toys through his mail-order company, Adam & Eve.
DKT’s donor list boasts abortion philanthropists like the Buffett, Packard, Hewlett, and Gates Foundations. In 2016 alone, the Bill & Melinda Gates Foundation awarded DKT International a combination $25 million grant and $12.5 million loan to “expand the sale of contraceptives.” According to Inside Philanthropy, “The Gates Foundation has been funding DKT’s sexual and reproductive health work since the late 1990s, starting with a $4.3 million grant… In 2001, Gates began supporting DKT’s work specifically related to birth control and family planning.”
The Gates Foundation’s grants to DKT International for “family planning” have been in the millions, totaling nearly $90 million since 1999. According to public reports, between 2014 and 2019 the David and Lucile Packard Foundation contributed nearly $3.5 million in grants to DKT, Hewlett contributed $4.4 million, while DKT International’s largest donor, the Buffett Foundation, granted over $170 million (between 2013 and 2020) to the international abortion pill company.
DKT’s board currently includes Matthew Reeves, M.D, an abortionist founder of the Dupont Clinic in D.C., which advertises late abortion after 26 weeks of pregnancy and recently announced plans to expand as an “all-trimester” facility in California. The opening of that facility in Beverly Hills appears to have been thwarted due to pro-life intervention. Reeves’ online bio reveals he served as Medical Director at the National Abortion Federation. His LinkedIn page shows that since 2018, he has served as Chairperson of the National Medical Committee of the Planned Parenthood Federation and worked at Planned Parenthood of Metropolitan D.C. and the now-disaffiliated Planned Parenthood Golden Gate.
DKT’s U.S. abortion pill division
Bloomberg’s investigation failed to note is that DKT International’s U.S. division (FemHealth USA, Inc.), operates under the name Carafem as a national abortion pill chain. FemHealth’s connection is confirmed by DKT’s financial audits with Carafem’s donation page, clearly writing that FemHealth USA is “doing business as carafem.” And according to an archived page from Carafem’s website, FemHealth was “established in 2013 as a 501c3 non-profit social enterprise to deliver early, safe abortion services and family planning products in the USA and to take advantage of new efficiencies, new technology, and new approaches in the delivery of care.”
Carafem, founded in 2013, was part of Gynuity Health Project’s infamous telabortion trials, which led to the Food and Drug Administration’s (FDA) decision to permanently allow abortion pill sales by mail. DKT CEO Christopher Purdy also serves as Carafem’s President and CEO.
Carafem’s latest (2023) annual report boasts DKT International as a major donor. Both Carafem (the public face of FemHealth) and DKT International have deep connections to some of the richest billionaire abortion philanthropists in the world and are funded by the Packard Foundation, which invested millions into the U.S. abortion pill manufacturer Danco as well as the generic manufacturer, GenBioPro.
Comentarios